Martine Bagot, Youn H. Kim, Caroline Ram-Wolff, Larisa J. Geskin, Pablo L. Ortiz-Romero, Ellen Kim, Neha Mehta-Shah, Olivier Dereure, Saskia Oro, Marie Beylot-Barry, Stéphane Dalle, Eric Jacobsen, Frederick Lansigan, Lubomir Sokol, Pier Luigi Zinzani, Maxime Battistella, Alejandro Gru, Hélène Moins-Teisserenc, Julien Viotti, Christine Paiva, Pierluigi Porcu
{"title":"拉库他单抗在复发和难治性ssamzary综合征患者中的应用:TELLOMAK 2期试验的长期随访","authors":"Martine Bagot, Youn H. Kim, Caroline Ram-Wolff, Larisa J. Geskin, Pablo L. Ortiz-Romero, Ellen Kim, Neha Mehta-Shah, Olivier Dereure, Saskia Oro, Marie Beylot-Barry, Stéphane Dalle, Eric Jacobsen, Frederick Lansigan, Lubomir Sokol, Pier Luigi Zinzani, Maxime Battistella, Alejandro Gru, Hélène Moins-Teisserenc, Julien Viotti, Christine Paiva, Pierluigi Porcu","doi":"10.1016/j.ejca.2025.115861","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"229 ","pages":""},"PeriodicalIF":7.1000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Lacutamab in patients with relapsed and refractory Sézary Syndrome: long term follow-up from the TELLOMAK Phase 2 Trial\",\"authors\":\"Martine Bagot, Youn H. Kim, Caroline Ram-Wolff, Larisa J. Geskin, Pablo L. Ortiz-Romero, Ellen Kim, Neha Mehta-Shah, Olivier Dereure, Saskia Oro, Marie Beylot-Barry, Stéphane Dalle, Eric Jacobsen, Frederick Lansigan, Lubomir Sokol, Pier Luigi Zinzani, Maxime Battistella, Alejandro Gru, Hélène Moins-Teisserenc, Julien Viotti, Christine Paiva, Pierluigi Porcu\",\"doi\":\"10.1016/j.ejca.2025.115861\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":11980,\"journal\":{\"name\":\"European Journal of Cancer\",\"volume\":\"229 \",\"pages\":\"\"},\"PeriodicalIF\":7.1000,\"publicationDate\":\"2025-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0959804925006902\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0959804925006902","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
期刊介绍:
The European Journal of Cancer (EJC) serves as a comprehensive platform integrating preclinical, digital, translational, and clinical research across the spectrum of cancer. From epidemiology, carcinogenesis, and biology to groundbreaking innovations in cancer treatment and patient care, the journal covers a wide array of topics. We publish original research, reviews, previews, editorial comments, and correspondence, fostering dialogue and advancement in the fight against cancer. Join us in our mission to drive progress and improve outcomes in cancer research and patient care.